Fig. 1
The prognostic value of intratumoral Siglec-10hi cell infiltration in patients with HCC. a, b OS (a) and RFS (b) curves of patients with low and high intratumoral Siglec-10hi cells infiltration in the discovery set (n = 115). c, d OS (c) and RFS (d) curves of patients with low and high intratumoral Siglec-10hi cell infiltration in the validation set (n = 120). e, f Multivariate Cox proportional hazards regression analysis of OS (e) and RFS (f) for clinicopathological parameters in the total cohort including the discovery set and validation set (n = 235). Intratumoral Siglec-10+ cells were detected by IHC on TMAs